Concepedia

B.J. Monk

BM

Statistics

Publications

15

Citations

383

H-Index

12

Active since

1995

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Creighton University

University of Arizona

Charles University

St. Joseph's Hospital and Medical Center

B.J. Monk is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and chemotherapy.

Publications per year

1995–2023

15

Publications

15

Effect of BRCA1 and XPG mutations on treatment response to trabectedin and pegylated liposomal doxorubicin in patients with advanced ovarian cancer: exploratory analysis of the phase 3 OVA-301 study

B.J. Monk, Prafull Ghatage, Trilok Parekh et al. · Annals of Oncology · 2015 · 65 citations

, , +15

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer delays third-line chemotherapy and prolongs the platinum-free interval

Stuart Kaye, Nicoletta Colombo, B.J. Monk et al. · Annals of Oncology · 2010 · 59 citations · Full text

, , +15

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

S. Diane Yamada, B.J. Monk · Yearbook of Obstetrics Gynecology and Women s Health · 2006 · 40 citations

, , +13

Inclusion, diversity, equity, and access (IDEA) in gynecologic cancer clinical trials: A joint statement from GOG foundation and Society of Gynecologic Oncology (SGO)

Bhavana Pothuri, Stephanie V. Blank, Tashanna Myers et al. · Gynecologic Oncology · 2023 · 39 citations

, , +16

Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II

MHM Oonk, Brian M. Slomovitz, Peter Baldwin et al. · International Journal of Gynecological Cancer · 2019 · 25 citations

, , +17

1–5 of 15